RxDoctor Payments Data

Meena Singh, MD

Dermatology · Overland Park, KSNPI 1275700528

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $115,634 of the $180,948 with a category attached, or 63.9%. 44 manufacturers reported payments, led by Pfizer at 46.0% of the total. 2025 is the largest year on record at $78,891, more than ten times the $1,823 reported in 2019. Among dermatology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$180,948in general payments, 2019–2025

Across 856 payments — averaging $211.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$83K
  • Lilly USA, LLC$47K
  • Sun Pharmaceutical Industries Inc.$21K
  • AbbVie$17K
  • Arcutis Biotherapeutics, Inc.$5K
  • Johnson & Johnson$724
  • plus $6K from 38 others
$25,800in research payments, 2019–2025

Across 3 payments — averaging $8600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$26K

What the payments were for

  • Consulting fees$27,35415%
  • Speaking & faculty fees$115,63464%
  • Travel & lodging$21,77412%
  • Food & beverage$16,0319%
  • Education$1560%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$180,948 in reported general payments places this provider in the 95th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$439,682
Medicare patients
469
Services billed
2,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dutasteride375$10,302
Minoxidil785$7,043
Doxycycline Hyclate164$2,535
Finasteride157$1,664
Gentamicin Sulfate34$1,339
Clobetasol Propionate31$1,271
Fluocinolone AcetonideFluocinolone/Shower Cap32$1,099
Spironolactone67$545
Triamcinolone Acetonide19$388
Ciprofloxacin Hcl77$385
Mometasone Furoate11$307
Mupirocin42$288
Bicalutamide17$255
Ketoconazole22$200
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$162

Paid to pharmacies, not to this prescriber.

Other dermatology in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →